STERNE
Provides 3D silicone printing services for prototyping and production of technical silicone devices, specializing in medical applications.
- CEO / Founder
- Christophe Torres
- Team Size
- 51-200
- Stage
- Active
- Total Funding
- Undisclosed
- Latest Round
- Debt Financing (LBO) - Undisclosed - April 2024
- Key Investors
- IDI Group; BNP Paribas Développement; Maelo Capital; CASRA Capital; EXSTO Group
Technology & Products
Key Products
3D silicone printing services; Silicone prototyping; Silicone device manufacturing
Technological Advantage
Combines traditional silicone processing (extrusion, injection) with additive manufacturing for rapid prototyping and complex designs, supported by ISO-certified clean rooms.
Differentiation
Value Proposition
Reduces prototyping lead times and enables complex silicone geometries through additive manufacturing, complementing traditional silicone processing methods.
How They Differentiate
Specializes in silicone additive manufacturing with a focus on medical-grade applications, offering integrated services from design to production in clean room environments.
Market & Competition
Target Customers
Medical device manufacturers, industrial clients needing silicone components
Industry Verticals
Medical; Industrial
Competitors
Spectroplast; ACEO; Wacker Chemie
Growth & Milestones
Growth Metrics
Annual revenue of $5.1 million in 2025, constant growth since 1996, 64 employees with 60% revenue from medical market and 25% export revenue as of 2022 integration into EXSTO Group
Major Milestones
Founded in 1996; Joined EXSTO Group in January 2022; Developed proprietary 3D silicone printing technology
Notable Customers
Sartorius Stedim Biotech (SSB)